EUVIMEDEUVIMED entdecken
Crossref

Improvement in antipsychotic-induced hyperprolactinemia with the addition of aripiprazole in schizophrenic patients

Kazuo Mihara, Goyo Nagai, Akifumi Nakamura, Yasuhide Fukuji, Takeshi Suzuki, Tsuyoshi Kondo

Clinical Neuropsychopharmacology and Therapeutics · 2010

DOI: 10.5234/cnpt.1.1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Neuropsychopharmacology and Therapeutics, 2010. Verfasst von Kazuo Mihara und 5 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Mihara, K., Nagai, G., Nakamura, A., Fukuji, Y., Suzuki, T., & Kondo, T. (2010). Improvement in antipsychotic-induced hyperprolactinemia with the addition of aripiprazole in schizophrenic patients. Clinical Neuropsychopharmacology and Therapeutics. https://doi.org/10.5234/cnpt.1.1

Vancouver

Mihara K, Nagai G, Nakamura A, Fukuji Y, Suzuki T, Kondo T. Improvement in antipsychotic-induced hyperprolactinemia with the addition of aripiprazole in schizophrenic patients. Clinical Neuropsychopharmacology and Therapeutics. 2010. doi:10.5234/cnpt.1.1

BibTeX
@article{Mihara2010,
  author = {Mihara, Kazuo and Nagai, Goyo and Nakamura, Akifumi and Fukuji, Yasuhide and Suzuki, Takeshi and Kondo, Tsuyoshi},
  title = {Improvement in antipsychotic-induced hyperprolactinemia with the addition of aripiprazole in schizophrenic patients},
  journal = {Clinical Neuropsychopharmacology and Therapeutics},
  year = {2010},
  doi = {10.5234/cnpt.1.1}
}
Kostenlos starten →